New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) regulates abnormal blood vessel growth in the damaged retina, which can cause vision loss or impairment.
Targeting ADAM10 may offer hope for retinal disease treatment
- Post author:admin
- Post published:June 25, 2025
- Post category:uncategorized